The global radiopharmaceuticals market is set for robust growth, with an estimated valuation of US$ 6,972.1 million in 2024 and projections to exceed US$ 11,635 million by 2034. This expansion represents a CAGR of 3.4% during the forecast period, driven by advancements in radioisotope applications and growing awareness of their benefits in medical diagnostics and …